S E Manley

Summary

Affiliation: University Hospital Birmingham
Country: UK

Publications

  1. ncbi Standardization of glycated haemoglobin
    Sally M Marshall
    Ann Clin Biochem 39:78-9. 2002
  2. ncbi Validation of an algorithm combining haemoglobin A(1c) and fasting plasma glucose for diagnosis of diabetes mellitus in UK and Australian populations
    S E Manley
    Clinical Biochemistry, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK
    Diabet Med 26:115-21. 2009
  3. ncbi Preanalytical, analytical, and computational factors affect homeostasis model assessment estimates
    Susan E Manley
    Clinical Biochemistry, University Hospital Birmingham NHS Foundation Trust, University of Birmingham, Birmingham, UK
    Diabetes Care 31:1877-83. 2008
  4. ncbi Estimated average glucose derived from HbA1c eAG: report from European Association for the Study of Diabetes (EASD), Amsterdam 2007
    S E Manley
    Clinical Biochemistry, University Hospital Birmingham NHS Trust, Brimingham, UK
    Diabet Med 25:126-8. 2008
  5. ncbi Comparison of 11 human insulin assays: implications for clinical investigation and research
    Susan E Manley
    Department of Clinical Biochemistry, University Hospital Birmingham NHS Foundation Trust, University of Birmingham, Birmingham, United Kingdom
    Clin Chem 53:922-32. 2007
  6. ncbi Calibration of HbA1c and its measurement in the presence of variant haemoglobins: report on questionnaire to manufacturers
    S E Manley
    Department of Clinical Biochemistry, University Hospital Birmingham NHS Trust, Selly Oak Hospital, Raddlebarn Road, Birmingham, B29 6JD, UK
    Ann Clin Biochem 43:135-45. 2006
  7. ncbi Introduction of IFCC reference method for calibration of HbA: implications for clinical care
    S Manley
    Clinical Biochemistry, University Hospital Birmingham NHS Trust, Birmingham, UK
    Diabet Med 21:673-6. 2004
  8. ncbi Haemoglobin A1c--a marker for complications of type 2 diabetes: the experience from the UK Prospective Diabetes Study (UKPDS)
    Susan Manley
    Department of Clinical Biochemistry, University Hospital Birmingham, Birmingham, UK
    Clin Chem Lab Med 41:1182-90. 2003
  9. ncbi Randomized dose ranging study of the reduction of fasting and postprandial glucose in type 2 diabetes by nateglinide (A-4166)
    F M Gribble
    Department of Clinical Biochemistry, Addenbrooke's Hospital, Cambridge, UK
    Diabetes Care 24:1221-5. 2001
  10. ncbi UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine
    Viti Kothari
    Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Radcliffe Infirmary, Oxford, United Kingdom
    Stroke 33:1776-81. 2002

Detail Information

Publications10

  1. ncbi Standardization of glycated haemoglobin
    Sally M Marshall
    Ann Clin Biochem 39:78-9. 2002
  2. ncbi Validation of an algorithm combining haemoglobin A(1c) and fasting plasma glucose for diagnosis of diabetes mellitus in UK and Australian populations
    S E Manley
    Clinical Biochemistry, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK
    Diabet Med 26:115-21. 2009
    ..To determine whether glycated haemoglobin (HbA(1c)) can be used in combination with fasting plasma glucose (FPG) for the diagnosis of diabetes in patients with impaired fasting glucose (IFG) and in a broader spectrum of patients...
  3. ncbi Preanalytical, analytical, and computational factors affect homeostasis model assessment estimates
    Susan E Manley
    Clinical Biochemistry, University Hospital Birmingham NHS Foundation Trust, University of Birmingham, Birmingham, UK
    Diabetes Care 31:1877-83. 2008
    ..We investigated how beta-cell function and insulin sensitivity or resistance are affected by the type of blood sample collected or choice of insulin assay and homeostatis model assessment (HOMA) calculator (http://www.dtu.ox.ac.uk)...
  4. ncbi Estimated average glucose derived from HbA1c eAG: report from European Association for the Study of Diabetes (EASD), Amsterdam 2007
    S E Manley
    Clinical Biochemistry, University Hospital Birmingham NHS Trust, Brimingham, UK
    Diabet Med 25:126-8. 2008
  5. ncbi Comparison of 11 human insulin assays: implications for clinical investigation and research
    Susan E Manley
    Department of Clinical Biochemistry, University Hospital Birmingham NHS Foundation Trust, University of Birmingham, Birmingham, United Kingdom
    Clin Chem 53:922-32. 2007
    ..The American Diabetes Association task force on standardization of insulin assays in 1996 showed wide variation in assay bias. Newer assays are specific for insulin, with several now available on automated immunoassay analyzers...
  6. ncbi Calibration of HbA1c and its measurement in the presence of variant haemoglobins: report on questionnaire to manufacturers
    S E Manley
    Department of Clinical Biochemistry, University Hospital Birmingham NHS Trust, Selly Oak Hospital, Raddlebarn Road, Birmingham, B29 6JD, UK
    Ann Clin Biochem 43:135-45. 2006
    ....
  7. ncbi Introduction of IFCC reference method for calibration of HbA: implications for clinical care
    S Manley
    Clinical Biochemistry, University Hospital Birmingham NHS Trust, Birmingham, UK
    Diabet Med 21:673-6. 2004
    ..The UK HbA(1c) Standardization Committee was set up to hold "a watching brief " on HbA(1c) especially with relation to reporting of HbA(1c) in other countries...
  8. ncbi Haemoglobin A1c--a marker for complications of type 2 diabetes: the experience from the UK Prospective Diabetes Study (UKPDS)
    Susan Manley
    Department of Clinical Biochemistry, University Hospital Birmingham, Birmingham, UK
    Clin Chem Lab Med 41:1182-90. 2003
    ..The UKPDS risk engine derived from the UKPDS database calculates coronary heart disease risk using HbA1c as a continuous variable and could now replace the Framingham equations for patients with type 2 diabetes...
  9. ncbi Randomized dose ranging study of the reduction of fasting and postprandial glucose in type 2 diabetes by nateglinide (A-4166)
    F M Gribble
    Department of Clinical Biochemistry, Addenbrooke's Hospital, Cambridge, UK
    Diabetes Care 24:1221-5. 2001
    ..Administered 5 min before a meal, nateglinide reduced the postprandial glucose excursion by 64%. With its rapid onset and short duration of action, nateglinide is a promising oral prandial therapy in type 2 diabetes...
  10. ncbi UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine
    Viti Kothari
    Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Radcliffe Infirmary, Oxford, United Kingdom
    Stroke 33:1776-81. 2002
    ..CONCLUSIONS: This model forecasts the absolute risk of a first stroke in people with type 2 diabetes using variables readily available in routine clinical practice...